Prevalence of urinary incontinence in pregnant women in Turkey: A systematic review and meta-analysis.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
May 2023
Historique:
received: 29 12 2022
revised: 04 03 2023
accepted: 18 03 2023
medline: 17 4 2023
pubmed: 2 4 2023
entrez: 1 4 2023
Statut: ppublish

Résumé

Urinary incontinence is a common complaint in pregnant women. The prevalence of urinary incontinence increases as the week of gestation progresses. This study was conducted to determine the prevalence of urinary incontinence in pregnant women, types of urinary incontinence during pregnancy, and the prevalence of urinary incontinence by trimesters in Turkey. This study is a systematic review and meta-analysis study. The publications meeting the inclusion criteria were searched between the dates September 1-30, 2022. A search was done in the PubMed and ScienceDirect, MEDLINE, Ovid, EBSCO CINAHL Plus, and Cochrane Library databases. The methodological quality of the studies was examined with the checklist developed by the Joanna Briggs Institute. Twenty articles were included in this study. According to the study results, the estimated urinary incontinence prevalence in pregnant women was 35 % (95 % CI: 0.288-0.423 Z:-3.984, p = 0.000, I The present study revealed that pregnancy increased the probability of urinary incontinence. While it is determined to be mostly experienced in the third trimester, approximately-one-third of pregnant women experience stress urinary incontinence. PROSPERO Registration no: CRD42022338643.

Sections du résumé

BACKGROUND AND OBJECTIVE OBJECTIVE
Urinary incontinence is a common complaint in pregnant women. The prevalence of urinary incontinence increases as the week of gestation progresses. This study was conducted to determine the prevalence of urinary incontinence in pregnant women, types of urinary incontinence during pregnancy, and the prevalence of urinary incontinence by trimesters in Turkey.
STUDY DESING METHODS
This study is a systematic review and meta-analysis study. The publications meeting the inclusion criteria were searched between the dates September 1-30, 2022. A search was done in the PubMed and ScienceDirect, MEDLINE, Ovid, EBSCO CINAHL Plus, and Cochrane Library databases. The methodological quality of the studies was examined with the checklist developed by the Joanna Briggs Institute.
RESULTS RESULTS
Twenty articles were included in this study. According to the study results, the estimated urinary incontinence prevalence in pregnant women was 35 % (95 % CI: 0.288-0.423 Z:-3.984, p = 0.000, I
CONCLUSION CONCLUSIONS
The present study revealed that pregnancy increased the probability of urinary incontinence. While it is determined to be mostly experienced in the third trimester, approximately-one-third of pregnant women experience stress urinary incontinence. PROSPERO Registration no: CRD42022338643.

Identifiants

pubmed: 37003240
pii: S0301-2115(23)00109-4
doi: 10.1016/j.ejogrb.2023.03.019
pii:
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

162-168

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Husniye Dinc Kaya (H)

Istanbul University-Cerrahpaşa Faculty of Health Sciences Department of Midwifery, Turkey. Electronic address: husniyedinc@hotmail.com.

Sevil Gunaydin (S)

Istanbul University-Cerrahpaşa Faculty of Health Sciences Department of Midwifery, Turkey.

Elif Dogan (E)

Istanbul University-Cerrahpaşa Faculty of Health Sciences Department of Midwifery, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH